Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cinder Invest is a Swedish investment company established as a joint venture between AFA Försäkring, AMF, FAM (the Wallenberg family's holding company), the Fourth Swedish National Pension Fund (AP4), and SEB. Founded in 2020, the firm was created to provide equity and hybrid capital to viable medium-sized Swedish companies that were negatively impacted by the COVID-19 pandemic. While it operates as a generalist investment vehicle, Cinder Invest has a significant presence in the healthcare sector through its portfolio companies, such as Hermes Medical Solutions, which specializes in molecular imaging software for nuclear medicine. The company is currently in a management phase, focusing on the long-term development and eventual refinancing of its existing portfolio holdings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cinder Invest.